Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced

Kamilla Gömöri1,2,3,4, Melissa Herwig1,2,3, Roua Hassoun1,2,3

  • 1Department of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.

Insights

Volume overload causes heart dysfunction and stiffness by increasing oxidative stress and impairing protein quality control. Glutathione treatment reversed these pathological changes in cardiac remodeling.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Volume overload (VO) is a significant risk factor for cardiac morbidity and mortality.
  • Cardiac dysfunction is exacerbated by aging, metabolic issues, and imbalanced cellular redox.
  • Understanding early pathological changes in VO is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the early pathological mechanisms of cardiac remodeling in response to volume overload.
  • To assess the role of oxidative stress and protein quality control in VO-induced cardiac dysfunction.
  • To evaluate the therapeutic potential of glutathione in reversing VO-induced cardiac alterations.

Main Methods:

  • Volume overload was induced in Wistar rats via an aortocaval fistula.
  • Functional parameters were assessed using transthoracic echocardiography.
  • Oxidative stress markers, protein quality control markers (heat shock proteins, caspases), and titin oxidation were analyzed.

Main Results:

  • VO induced cardiac hypertrophy, mechanical dysfunction, and increased cardiomyocyte stiffness.
  • Elevated oxidative stress markers and impaired protein quality control were observed.
  • Glutathione treatment demonstrated a reversal of cardiac dysfunction and associated pathological markers.
  • Inflammatory signaling pathways remained unchanged, suggesting a primary role for oxidative stress.

Conclusions:

  • Early cardiac response to VO involves mechanical dysfunction and dysregulated signaling pathways.
  • Enhanced oxidative stress and impaired protein quality control are key contributors to VO-induced cardiac pathology.
  • Glutathione shows promise as a therapeutic agent for mitigating VO-induced cardiac damage.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
770